| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $50K | — |
| Cost of Revenue | $6K | — |
| Gross Profit | $44K | — |
| R&D Expense | $1.1M | -57.8% |
| SG&A Expense | $189K | — |
| Operating Income | -$5.0M | +15.9% |
| Interest Expense | $29K | -12.2% |
| Pre-tax Income | -$10.7M | +33.7% |
| Income Tax | -$97K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $4K | — |
| Inventory | $109K | — |
| Current Assets | $956K | -98.5% |
| Total Assets | $1.5M | -97.7% |
| Current Liabilities | $5.9M | -84.7% |
| Total Liabilities | $6.2M | -84.2% |
| Stockholders' Equity | -$4.7M | -119.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.4M | +47.4% |
| Capital Expenditures | $30K | +0.0% |
| Investing Cash Flow | -$749K | -2357.5% |
| Financing Cash Flow | $2.4M | -78.7% |
| Free Cash Flow | -$4.4M | +47.3% |
| Net Income | -$10.4M | +32.9% |
| EPS (Basic) | -$0.49 | +66.4% |
| EPS (Diluted) | -$0.49 | +66.4% |